Answers are grounded in this paper and cite their sources.
Large language model (LLM)-based chatbots are increasingly used for health information, but their performance in Parkinson’s disease (PD) patient education remains unclear. This study evaluated five widely used LLM-based chatbots in answering public questions about levodopa therapy. In this cross-sectional comparative study, ChatGPT, Gemini, Copilot, DeepSeek, and Doubao were assessed using a structured set of levodopa-related patient education questions. In the primary analysis, 265 responses were evaluated by five blinded raters for safety, accuracy, empathy, and information quality using predefined criteria, including DISCERN, EQIP, JAMA benchmark criteria, and the Global Quality Score. Readability was assessed using six established indices. An additional 265 responses were generated in an independent repeat-generation analysis using the same question set to assess response stability. Inter-rater agreement was high. Safe-response rates ranged from 86.8% to 94.3%. Accuracy differed significantly, with Copilot and DeepSeek showing the highest median scores, whereas empathy differences were modest and closely clustered. Doubao had the highest DISCERN and EQIP scores, while ChatGPT had the lowest information-quality scores. Gemini showed the best readability profile and Doubao the poorest. Repeat-generation analysis showed generally high stability, with 97.0% exact safety agreement and largely preserved model rankings. Current LLM-based chatbots generated generally informative English-language responses about levodopa therapy, but safety gaps, variable information quality, and poor readability remained. These findings reflect expert-rated output quality rather than demonstrated patient education effectiveness, and patient-centered validation is warranted.
No takes yet. Share an insight, caveat, or question.
Zuo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: